BROADWOOD CAPITAL INC — Form 4 insider transactions

BROADWOOD CAPITAL INC — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-04-27 Buy Insight Molecular Diagnostics Inc. — — — SEC filing
2026-04-27 Buy Insight Molecular Diagnostics Inc. 250,923 $3.64 $913,134 SEC filing
2026-04-24 Buy Insight Molecular Diagnostics Inc. — — — SEC filing
2026-04-24 Buy Insight Molecular Diagnostics Inc. 38,880 $3.53 $137,083 SEC filing
2026-04-23 Buy Insight Molecular Diagnostics Inc. — — — SEC filing
2026-04-23 Buy Insight Molecular Diagnostics Inc. 280,381 $3.50 $982,034 SEC filing
2026-04-20 Buy Insight Molecular Diagnostics Inc. — — — SEC filing
2026-04-20 Buy Insight Molecular Diagnostics Inc. 40,690 $3.88 $157,967 SEC filing
2026-04-17 Buy Insight Molecular Diagnostics Inc. — — — SEC filing
2026-04-17 Buy Insight Molecular Diagnostics Inc. 40,114 $3.57 $143,251 SEC filing
2026-04-16 Buy Insight Molecular Diagnostics Inc. — — — SEC filing
2026-04-16 Buy Insight Molecular Diagnostics Inc. 102,057 $3.45 $351,658 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →